Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-07

Clinical Trial Update: Neoadjuvant GW572016 to Treat Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of GW572016 for breast cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GW572016 (lapatinib)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-07